Aspirin protects against cancers expressing COX 2BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7604.1135-c (Published 31 May 2007) Cite this as: BMJ 2007;334:1135
Aspirin reduces the risk of colorectal cancer, but its effects seem confined to cancers that express the cyclo-oxygenase-2 (COX 2) enzyme, according to a large observational study. Regular use of aspirin was associated with a 36% decrease in the risk of colorectal …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial